Find us on:

LDN is short for Low Dose Naltrexone.

Naltrexone is a drug that was approved by the FDA in 1985 to treat opiate dependencies. It is marketed under the trade names ‘Revia®’ and ‘Depade®’ and in some countries (including the United States), an extended-release formulation is available as ‘Vivitrol®’. Naltrexone is commonly used at a dose of 50mg–100mg daily for treating opiate dependency.

The term ‘LDN’ refers to the use of Naltrexone at doses below 10mg per day. Naltrexone exhibits novel and paradoxical effects when administered as these low doses, as discovered by Dr. Ian S. Zagon and his team at Hershey Medical Center, Penn State University, in 1980.

Since this discovery, numerous laboratory and animal studies have been carried out to investigate the novel effects of LDN in cancer and autoimmune disorders. In 2007, results of the first clinical trial using LDN for Crohn's Disease were published (Smith JP et al. Am J Gastroenterol. 2007;102(4):820-8), followed by publication of a study on multiple sclerosis in 2008 (Gironi M et al. Multiple Sclerosis. 2008;14(8):1076-83) and fibromyalgia in 2009 (Younger J and Mackey S. Pain Med. 2009;10(4):663-72).

Further studies and research can be found here.

In order to understand how LDN works, it is crucial to briefly introduce the workings of the ‘natural opioid’ (endorphin) system.

Endorphins

Endorphins are opiate-like molecules produced naturally in the body. The term ‘endorphin’ comes from ‘endogenous morphine’, meaning that it is created within the body, and differentiating it from opioids that are administered from external sources.

Endorphins are produced in most cells in the body, and are important regulators of cell growth, and therefore the immune system. Disorders of the immune system can occur with unusually low levels of these endorphins. The particular endorphin that has been found to influence cell growth as well as immunity is called Opioid Growth Factor (OGF) or Met-Enkephalin.

For an endorphin such as OGF to exert its beneficial effects, it must interact with the body’s cells. It does this by binding to a receptor on the surface of the cells. The receptor to which OGF binds is the ‘Opioid Growth Factor Receptor’ (OGFr) – previously known as the Zeta (ζ) receptor.

Thus, for the endorphin system to be fully functional, two elements are required: opioid production and cell interaction.

Naltrexone Stimulates the OGF Receptors Producing Therapeutic Effect

Naltrexone is an externally administered drug that binds to opioid receptors. In doing so, it displaces the endorphins which were previously bound to the receptors. Specifically, by binding to the OGF receptors, it displaces the body’s naturally produced OGF.

As a consequence of this displacement, the affected cells become deficient in OGF and three things happen:

  1. Receptor production is increased, in order to try to capture more OGF.
  2. Receptor sensitivity is increased, also to try to capture more OGF.
  3. Production of OGF is increased, in order to compensate for the perceived shortage of OGF.

Since LDN blocks the OGF receptors only for a few hours before it is naturally excreted, what results is a rebound effect; in which both the production and utilization of OGF is greatly increased. Once the LDN has been metabolized, the elevated endorphins produced as a result of the rebound effect can now interact with the more-sensitive and more-plentiful receptors and assist in regulating cell growth and immunity.

Low Dose Naltrexone (LDN)

The duration of the rebound effect varies from individual to individual, but generally persists for about one day.

The benefits of the rebound effect can only be utilized by taking a low dose of regular Naltrexone. Taking a high dose of Naltrexone or using a timed-release formulation will result in continuous blockade of OGF receptors, and the rebound effect will not serve any useful purpose.

In scientific terminology, the use of regular-dose Naltrexone results in ‘continuous opioid receptor blockade’ whilst the use of LDN results in ‘intermittent opioid receptor blockade’. In order to benefit from the rebound effect and achieve the therapeutic benefit of LDN, it is essential to avoid timed-release (or slow-release) versions of Naltrexone.

Individuals vary in their metabolic speed and this will result in inter-patient variation in the speed at which LDN is eliminated from the body, as well as the length of the rebound effect. Whilst a single daily dose of between 3mg and 5mg will be suitable for most patients, individual modification of dosage or frequency is sometimes needed.

Low Dose Naltrexone (LDN) is being used as a regulator of the immune system, providing relief to patients with autoimmune diseases, and central nervous system disorders. Whilst it is not licensed by the FDA specifically for these conditions, physicians are permitted to prescribe LDN ‘off-label’ for treatments they think are appropriate.

The apparently diverse conditions in which LDN appears to have a therapeutic effect are united by their ability to benefit from increased levels of endorphins (naturally occurring opioids – specifically OGF).

In the interests of promoting further research into different uses of LDN, we encourage LDN users who are willing to be identified to share their experiences with LDN by clicking on Submit Your Story.

Examples of the successful use of LDN, supported by studies as well as reported by patients to date, include the following conditions:

foods that boost libido instantly just for him password depression medicine side effects cialis what does it do best time to take rapaflo erectile dysfunction at 30 huge penis glans cialis next day delivery usa everyday male what happens if a girl takes viagra 69 sexually pictures foods that lower testosterone male enhancement girth sudden ed ed and high blood pressure pimple on penis head oops sexy alpha male promotions ginkgo vitamins pro sexual sexual anxiety cure best muscle gaining pills erectile dysfunction percentage secondary impotence does height affect penile length how men can last longer dick wash natural treatments for ed does testosterone make you lose weight lisinopril and viagra performix super t cheapest drugs 72 hour sex pill big penis stories human growth hormone supplements generic revatio

weight loss spas justin mcelroy weight loss dr oz 21 day weight loss breakthrough vietnamese diet pills are acai bowls good for weight loss do ace diet pills really work best breakfast smoothie for weight loss ginnifer goodwin weight loss after baby weight loss candy dmn weight loss mother apple cider vinegar weight loss best weight loss diet for men hypnotist for weight loss gradual weight loss weight loss tea that works cat weight loss plan weight loss charleston wv 50 year old weight loss what weight loss pills have amphetamine sst weight loss pills dream body diet pills quick weight loss workouts taking fiber pills to lose weight best soups for weight loss two pills to lose weight best morning smoothie for weight loss quick weight loss centers of houston quick weight loss centers of georgia quick weight loss center ga pool exercises for weight loss quick weight loss home remedies in urdu punching bag weight loss real food diet weight loss oxycodone weight loss best way to lose weight weight loss pill walgreens

vape no A Tag

cbd shops near me cbd fort worth dropship cbd full spectrum cbd oil for sale near me vaping cbd flower types of medical marijuanas highest cbd strain 2017 cbd full spectrum oil does cbd show up in a blood test shop def cbd oil expensive cbd hemp oil cream cbd oil suppository edens herbals cbd oil gnome cbd oil how long does cbd oil stay fresh thc cbd test cbd oil great falls mt kid friendly restaurants sydney cbd status audio zilis ultracell full spectrum hemp cbd topical whiting clinic reviews revivid cbd oil well cbd what does don stand for cbd for heartburn trap 450 vape aspen valley cbd cigarettes weed side effects list fountain of health cbd reviews inneed of does cbd oil help reduce inflammation cbd z100 beam cbd oil best way to test for allergies to cbd oil is it safe to take cbd oil while breastfeeding